Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
about
Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementationTesting but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa.Assessment of service quality of public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional study.Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study.HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.Collective patient behaviours derailing ART roll-out in KwaZulu-Natal: perspectives of health care providers.Nanotechnology: a magic bullet for HIV AIDS treatment.Conceptions of agency and constraint for HIV-positive patients and healthcare workers to support long-term engagement with antiretroviral therapy care in Khayelitsha, South Africa.Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3A.Knowledge of HIV and its treatment among health care providers in South Africa.The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
P2860
Q33622913-C358454C-0109-480C-B501-488DB2022B12Q33858110-17DF3548-EA71-42FC-98BA-3EB386DA1759Q34003802-089D1F88-9533-4309-B809-AA747B5A9B06Q34360370-9293610D-3118-44F6-B258-6699E7A7C386Q34686754-A7F78AB2-DB13-4EE7-B7B1-FBBDF47F498DQ35532401-9F4803F1-EB0E-4CD4-B2CF-987184E39849Q35901619-19ABD9DC-6158-461E-804F-369DEDC2C21FQ36530478-6E2AF366-649C-4905-AB99-8F7A0C3BB9A4Q37152891-D6E91D36-806D-4934-9634-89D96D99D595Q38190581-A01A6836-6D52-40AC-BA15-C8EFB216B0D4Q38557982-B34651B2-C8A1-4638-AC42-DD8C02218664Q39767247-F60AA2EF-C688-43EC-8842-641C8F2C79C0Q42247345-FA0164FE-2D3D-41B1-8AF1-98EA5FD95849Q54671983-BAC41303-BA33-458C-AA33-ACDB16623011
P2860
Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Provision of antiretroviral th ...... enges and remaining obstacles.
@en
Provision of antiretroviral th ...... enges and remaining obstacles.
@nl
type
label
Provision of antiretroviral th ...... enges and remaining obstacles.
@en
Provision of antiretroviral th ...... enges and remaining obstacles.
@nl
prefLabel
Provision of antiretroviral th ...... enges and remaining obstacles.
@en
Provision of antiretroviral th ...... enges and remaining obstacles.
@nl
P356
P1476
Provision of antiretroviral th ...... enges and remaining obstacles.
@en
P2093
Bisola Ojikutu
Chris Jack
P304
P356
10.1086/521119
P407
P478
196 Suppl 3
P50
P577
2007-12-01T00:00:00Z